Eyecelerator @ American Academy of Ophthalmology (AAO)
- Presentation Title: Transformative Gene Therapies for the Treatment of Rare Inherited Retinal Diseases
- Presentation Content: Three-month pediatric and 18-month adult clinical data from the OPGx-LCA5 Phase 1/2 trial
- Presenter: Sally Tucker, Ph.D., Senior Vice President of Clinical Development, Opus Genetics
- Location: Orange County Convention Center, Orlando, FL